Medicare Enrolled

Dr. Andra Fee-Mulhearn, D.O., M.P.H

Pulmonary Disease · Meadville, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
765 LIBERTY ST STE 307B, Meadville, PA 16335
8143335691
Registered in NPPES since 2011
NPI: 1942590799 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fee-Mulhearn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fee-Mulhearn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fee-Mulhearn

Dr. Andra Fee-Mulhearn is a pulmonary disease specialist in Meadville, PA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Fee-Mulhearn performed 1,016 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Fee-Mulhearn received a total of $6,040 from 29 pharmaceutical and/or device companies across 360 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fee-Mulhearn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ Top 31% volume in PA $6,040 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,016
Medicare services
Top 31% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
304 $87 $213
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
113 $56 $143
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
95 $7 $68
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
94 $7 $105
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
92 $113 $359
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
91 $9 $78
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
60 $158 $566
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
55 $19 $56
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
43 $61 $170
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
25 $94 $224
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
19 $131 $436
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $98 $335
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
12 $61 $438
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,040
Total received (2018-2024)
Avg $863/year across 7 years
Top 27% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
360
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$996
2023
$911
2022
$823
2021
$632
2020
$454
2019
$983
2018
$1,240

Payments by company (2024)

Noah Medical Corporation
$646
GlaxoSmithKline, LLC.
$147
Inspire Medical Systems, Inc.
$53
GENZYME CORPORATION
$42
AstraZeneca Pharmaceuticals LP
$35
Regeneron Healthcare Solutions, Inc.
$20
Philips North America LLC
$19
Gilead Sciences, Inc.
$17
Amgen Inc.
$17
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,646
AstraZeneca Pharmaceuticals LP
$1,330
Noah Medical Corporation
$646
Boehringer Ingelheim Pharmaceuticals, Inc.
$514
Regeneron Healthcare Solutions, Inc.
$279
Grifols USA, LLC
$263
GENZYME CORPORATION
$238
Ethicon Inc.
$148
Philips Electronics North America Corporation
$148
Merck Sharp & Dohme Corporation
$126
SANOFI-AVENTIS U.S. LLC
$92
Novartis Pharmaceuticals Corporation
$76
Janssen Pharmaceuticals, Inc
$69
Mylan Specialty L.P.
$60
Inspire Medical Systems, Inc.
$53
Actelion Pharmaceuticals US, Inc.
$41
Shire North American Group Inc
$40
Sunovion Pharmaceuticals Inc.
$38
Genentech USA, Inc.
$34
Resmed Corp
$33
Amgen Inc.
$29
Monaghan Medical Corporation
$24
Philips North America LLC
$19
E.R. Squibb & Sons, L.L.C.
$19
Jazz Pharmaceuticals Inc.
$19
Gilead Sciences, Inc.
$17
Circassia Pharmaceuticals Inc
$17
Merck Sharp & Dohme LLC
$13
Z-Medica, LLC
$10
Top 3 companies account for 60.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AeroEclipse · Aeroeclipse · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · DreamStat Cpap Auto · DreamStation Cpap Auto · ELIQUIS · FASENRA · GALAXY · GLASSIA · INSPIRE · Monarch Platform · NUCALA · OFEV · OPSUMIT MACITENTAN · Prolastin-C Liquid · QuikClot · SEEBRI · SPIRIVA RESPIMAT · SRC Und · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · Trilogy 100 · Veklury · XARELTO · XOLAIR · Xolair · Xyrem · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Meadville?
Compare pulmonary diseases in the Meadville area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
4
County median income
$60,254
Nearest hospital to ZIP centroid (approximate)
MEADVILLE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fee-Mulhearn is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fee-Mulhearn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fee-Mulhearn performed 304 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fee-Mulhearn receive payments from pharmaceutical companies?
Yes. Dr. Fee-Mulhearn received a total of $6,040 from 29 companies across 360 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fee-Mulhearn's costs compare to other pulmonary diseases in Meadville?
Dr. Fee-Mulhearn's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fee-Mulhearn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →